Ondansetron is a selective blocking agent of the serotonin 5-HT3 receptor type.
Granisetron is a selective 5-hydroxytryptamine3 (5-HT3) receptor antagonist with little or no affinity for other serotonin receptors, including 5-HT1; 5-HT1A; 5-HT1B/C; 5-HT2; for α1-, α2-, or β-adrenoreceptors; for dopamine-D2; or for histamine-H1; benzodiazepine; picrotoxin or opioid receptors.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 6 Sep 2009 • 1 answer
Posted 20 Sep 2010 • 3 answers
Posted 14 Nov 2010 • 3 answers
Posted 16 Dec 2013 • 1 answer
Posted 8 Aug 2015 • 3 answers